Skip to main content
. 2016 Jun 28;2016:7056492. doi: 10.1155/2016/7056492

Figure 3.

Figure 3

Cell-count and vitality (Trypan blue-staining) of HepG2/C3A cells (biosensor-test) incubated with plasma from septic patients before extracorporeal treatments compared to plasma from patients after extracorporeal granulocyte treatments (Mann-Whitney U test; n = 10; median/0.25–0.75 quartile).